These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 18986003)
1. Close association of vascular and valvular calcification and prognosis of patients on continuous ambulatory peritoneal dialysis. Gen S; Inoue T; Nodaira Y; Ikeda N; Kobayashi K; Watanabe Y; Kanno Y; Nakamoto H; Suzuki H Adv Perit Dial; 2008; 24():60-4. PubMed ID: 18986003 [TBL] [Abstract][Full Text] [Related]
2. Association of conjunctival and corneal calcification with vascular calcification in dialysis patients. Seyahi N; Altiparmak MR; Kahveci A; Yetik H; Kanberoglu K; Serdengecti K; Ataman R; Erek E Am J Kidney Dis; 2005 Mar; 45(3):550-6. PubMed ID: 15754277 [TBL] [Abstract][Full Text] [Related]
3. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935 [TBL] [Abstract][Full Text] [Related]
4. [Study on vascular calcification in patients on continuous ambulatory peritoneal dialysis (CAPD): special reference to active vitamin D (VD) treatment]. Yokoyama K Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1171-80. PubMed ID: 8264107 [TBL] [Abstract][Full Text] [Related]
5. Clinical presentation in patients more than 80 years of age at the start of peritoneal dialysis. Sueyoshi K; Inoue T; Kojima E; Sato T; Tsuda M; Kikuta T; Watanabe Y; Takane H; Takenaka T; Suzuki H Adv Perit Dial; 2011; 27():71-6. PubMed ID: 22073833 [TBL] [Abstract][Full Text] [Related]
6. Myocardial texture and cardiac calcification in uremia. Wade MR; Chen YJ; Soliman M; Kaptein E; Massry SG; Rahimtoola SH; Chandraratna PA Miner Electrolyte Metab; 1993; 19(1):21-4. PubMed ID: 8345830 [TBL] [Abstract][Full Text] [Related]
7. Reversible peritoneal calcification in a patient treated by CAPD. Kitoh C; Miyagi K; Onoe T; Katano K; Shimada T; Takegoshi T Clin Nephrol; 1999 Nov; 52(5):329-32. PubMed ID: 10584998 [TBL] [Abstract][Full Text] [Related]
8. Audit of a decade of continuous ambulatory peritoneal dialysis. Fox JG; Fowler I; Boulton-Jones JM Nephrol Dial Transplant; 1993; 8(3):240-3. PubMed ID: 8385292 [TBL] [Abstract][Full Text] [Related]
9. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. Leskinen Y; Paana T; Saha H; Groundstroem K; Lehtimäki T; Kilpinen S; Huhtala H; Airaksinen J J Heart Valve Dis; 2009 Jul; 18(4):429-38. PubMed ID: 19852148 [TBL] [Abstract][Full Text] [Related]
10. Residual renal function plays an important role in regulating parathyroid hormone in patients on continuous ambulatory peritoneal dialysis. Okada S; Inoue T; Nakamoto H; Ikeda N; Sugahara S; Shoda J; Okada H; Kanno Y; Suzuki H Adv Perit Dial; 2007; 23():150-4. PubMed ID: 17886623 [TBL] [Abstract][Full Text] [Related]
11. Risk factors and cause of removal of peritoneal dialysis catheter in patients on continuous ambulatory peritoneal dialysis. Nodaira Y; Ikeda N; Kobayashi K; Watanabe Y; Inoue T; Gen S; Kanno Y; Nakamoto H; Suzuki H Adv Perit Dial; 2008; 24():65-8. PubMed ID: 18986004 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of mitral and aortic valve sclerosis for survival in end-stage renal disease on continuous ambulatory peritoneal dialysis. Hüting J Nephron; 1993; 64(1):63-8. PubMed ID: 8502338 [TBL] [Abstract][Full Text] [Related]
13. Symptomatic exacerbation of peripheral vascular disease with chronic ambulatory peritoneal dialysis. Brown PM; Johnston KW; Fenton SS; Cattran DC Clin Nephrol; 1981 Nov; 16(5):258-61. PubMed ID: 7307353 [TBL] [Abstract][Full Text] [Related]
14. Management of vascular calcification in CKD patients. Massry SG; Smogorzewski M Semin Nephrol; 2006 Jan; 26(1):38-41. PubMed ID: 16412824 [TBL] [Abstract][Full Text] [Related]
15. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. Wang AY; Wang M; Woo J; Lam CW; Li PK; Lui SF; Sanderson JE J Am Soc Nephrol; 2003 Jan; 14(1):159-68. PubMed ID: 12506148 [TBL] [Abstract][Full Text] [Related]
16. Continuous ambulatory peritoneal dialysis is effective for patients with severe congestive heart failure. Takane H; Nakamoto H; Arima H; Shoda J; Moriwaki K; Ikeda N; Kobayashi K; Kanno Y; Sugahara S; Okada H; Suzuki H Adv Perit Dial; 2006; 22():141-6. PubMed ID: 16983958 [TBL] [Abstract][Full Text] [Related]
17. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis. Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317 [TBL] [Abstract][Full Text] [Related]
18. Localization and extent of peritoneal calcification in three uremic patients on continuous ambulatory peritoneal dialysis. Dejima K; Mitsuhashi H; Yasuda G; Hirawa N; Ikeda Y; Umemura S Ther Apher Dial; 2008 Oct; 12(5):413-6. PubMed ID: 18937728 [TBL] [Abstract][Full Text] [Related]
19. Hypoparathyroidism potentiates cardiovascular complications through disturbed calcium metabolism: possible risk of vitamin D(3) analog administration in dialysis patients with end-stage renal disease. Tsuchihashi K; Takizawa H; Torii T; Ikeda R; Nakahara N; Yuda S; Kobayashi N; Nakata T; Ura N; Shimamoto K Nephron; 2000 Jan; 84(1):13-20. PubMed ID: 10644903 [TBL] [Abstract][Full Text] [Related]